Yaping Tu, PhD, is an accomplished professional in the field of clinical pharmacology with extensive experience in leading drug development efforts across various organizations. Currently serving as the Executive Director and Head of Clinical Pharmacology at ImmunoGen, Inc., Yaping has previously held significant positions including Director of Clinical Pharmacology at PTC Therapeutics, Inc., and Director of DMPK, Toxicology, and Clinical Pharmacology at Mirata Biopharma. Additional expertise was gained as Senior Chief Scientist in DMPK at GlaxoSmithKline and as Associate Director of DMPK at Genelabs Technologies. Yaping Tu's comprehensive background underscores a strong commitment to advancing pharmacological research and development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices